Ajax-Loading

Astellas Pharma Inc. - Accounts Payable

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Accounts-Payable" stands at 168.65 Billion Japanese Yens as of 09/30/2025.

As of the end of Astellas Pharma Inc.'s second quarter, the item "Accounts Payable" stands at 168.65 Billion JPY. This represents an increase of 1.67 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 4.65 percent compared to the value the year prior.
The 1 year change in percent is 4.65.
The 3 year change in percent is 15.10.
The 5 year change in percent is 48.58.
The 10 year change in percent is -16.52.

The Serie's long term average value is 151.23 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 11.52 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2012, to it's latest available value, on 09/30/2025, is +91.94%.
The Serie's change in percent from it's maximum value, on 03/31/2015, to it's latest available value, on 09/30/2025, is -25.57%.

Accounts Payable for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Accounts Payable905,699,262,464.00
LogoJohnson & Johnson - Accounts Payable486,508,953,600.00
LogoAbbVie Inc - Accounts Payable399,570,305,024.00
LogoRoche Holding AG - Accounts Payable317,433,206,677.55
LogoAstraZeneca PLC - Accounts Payable280,205,508,085.11